Oncology & Cancer

Investigational PARP inhibitor promising in BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented ...

Diseases, Conditions, Syndromes

Probiotics found to reduce hepatic encephalopathy

Probiotics could emerge as a treatment plan to manage hepatic encephalopathy (HE) therapy after a new study announced at the International Liver Congress 2013 found they significantly reduced development of the notoriously ...

Oncology & Cancer

Extra cash helps patients cope with cancer

Welfare rights advice has been shown to help patients with cancer and their carers receive millions in unclaimed benefits to help cope with the disease.

page 11 from 12